{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "EMA Clinical Data Publication Policy to Cover All New Marketing Authorization Applications, Line Extensions and Major Clinical Type II Variations Starting Q2 2025",
    "url": "https://www.lexblog.com/2024/11/27/ema-clinical-data-publication-policy-to-cover-all-new-marketing-authorization-applications-line-extensions-and-major-clinical-type-ii-variations-starting-q2-2025-2/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-3M84XAW7",
        "url": "https://www.lexblog.com/lib/3M84XAW7/"
    },
    "datePublished": "2024-11-27T13:05:39-05:00",
    "dateModified": "2024-11-27T10:06:27-05:00",
    "author": {
        "@type": "Person",
        "name": "Grant Castle, Robin Blaney"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Covington & Burling LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Global Policy Watch",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.globalpolicywatch.com/?p=15248",
    "sourceStability": "may-move"
}